Overview

Mepolizumab in Nasal Polyposis

Status:
Completed

Trial end date:
2014-12-05

Target enrollment:

Participant gender:

Summary

A two-part, randomised, double-blind, placebo controlled, multi-centre study to investigate the use of mepolizumab (SB-240563) in reducing the need for surgery in subjects with severe bilateral nasal polyposis.

Phase:

Phase 2

Details

Lead Sponsor:

GlaxoSmithKline